Sequence variation, linkage disequilibrium and association with Crohn's disease on chromosome 5q31

Genes and Immunity

Volumn 7, Issue 5, 2006, Pages 359-365

  Onnie, C ^a   Fisher, S A ^a   King, K ^a   Mirza, M ^a   Roberts, R ^a   Forbes, A ^b   Sanderson, J ^c   Lewis, C M ^a   Mathew, C G ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 1; ORGANIC CATION TRANSPORTER; PROTEIN SLC22A4; RAD50 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME 5Q; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; GENE EXPRESSION REGULATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; TH2 CELL;

BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 5; COHORT STUDIES; CROHN DISEASE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; ORGANIC CATION TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS);

EID: 33746375981     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364307     Document Type: Article

References (36)

1. Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-1517.
2. Mathew CG, Lewis CM. Genetics of inflammatory bowel disease: Progress and prospects. Hum Mol Genet 2004; 13: R161-R168 (Special Issue 1).
3. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
4. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R et al. A frameshift mutation in Nod2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606.
5. Hampe J, Cuthbert A, Croucher P, Mirza MM, Mascheretti S, Fisher S et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357: 1925-1928.
6. Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, Griffiths AM et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66: 1863-1870.
7. Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen Z et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001; 29: 223-228.
8. Mirza MM, Fisher SA, King K, Cuthbert AP, Hampe J, Sanderson J et al. Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease. Am J Hum Genet 2003; 72: 1018-1022.
9. Giallourakis C, Stoll M, Miller K, Hampe J, Lander E, Daly M et al. IBD5 is a general risk factor for inflammatory bowel disease: Replication of association with Crohn's disease and identification of a novel association with Ulcerative Colitis. Am J Hum Genet 2003; 78: 205-211.
10. Negoro K, McGovern DPB, Kinouchi Y, Takahashi S, Lench NJ, Shimosegawa T et al. Analysis of the IBD5 locus and potential gene-gene interactions in Crohn's disease. Gut 2003; 52: 541-546.
11. Daly MJ, Rioux JD, Schaffner SE, Hudson TJ, Lander ES. High-resolution haplotype structure in the human genome. Nat Genet 2001; 29: 229-232.
12. Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004; 36: 471-475.
13. Török HP, Glas J, Tonenchi L, Lohse P, Müller-Myhsok B, Limbersky O et al. Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut 2005; 54: 1354-1357.
14. Vermeire S, Pierik M, Hlavaty T, Claessens G, van Shuerbeeck N, Joossens S et al. Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD. Gastroenterology 2005; 129: 1845-1853.
15. Noble CL, Nimmo ER, Drummond H, Ho GT, Tenesa A, Smith L et al. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology 2005; 129: 1854-1864.
16. Trinh TT, Rioux JD. Understanding association and causality in the genetic studies of inflammatory bowel disease. Gastroenterology 2005; 129: 2106-2110.
17. Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N et al. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 1999; 21: 91-94.
18. Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 2003; 35: 341-348.
19. Donfack J, Schneider DH, Tan Z, Kirz T, Dubchak I, Frazer KA et al. Variation in conserved non-coding sequences on chromosome 5q and susceptibility to asthma and atopy. Resp Res 2005; 6: 145.
20. Ho P, Bruce IN, Silman A, Symmons D, Newman B, Young H et al. Evidence for common genetic control in pathways of inflammation for Crohn's disease and psoriatic arthritis. Arthritis Rheum 2005; 52: 3596-3602.
21. Frazer KA, Ueda Y, Zhu Y, Gifford VR, Garofalo MR, Mohandas N et al. Computational and biological analysis of 680 kb of DNA sequence from the human 5q31 cytokine gene cluster region. Genome Res 1997; 7: 495-512.
22. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 1998; 26: 362-367.
23. Ardle KG, Kruglyak L, Seielstad M. Patterns of linkage disequilibrium in the human genome. Nat Rev Genet 2002; 3: 299-309.
24. Luoni G, Forton J, Jallow M, Akha ES, Sisay-Joof F, Pinder M et al. Population-specific patterns of linkage disequilibrium in the human 5q31 region. Genes Immun 2005; 6: 723-727.
25. Newman B, Gu X, Wintle R, Cescon D, Yazdanpanah M, Liu X et al. A risk haplotype in the Solute Carrier Family 22A4/22A5 gene cluster influences phenotypic expression of Crohn's disease. Gastroenterology 2005; 128: 260-269.
26. Sallusto F, Reiner SL. Sliding doors in the immune response. Nat Immunol 2005; 6: 10-12.
27. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989; 170: 2-6.
28. King K, Moody A, Fisher SA, Mirza MM, Cuthbert AP, Hampe J et al. Genetic variation in the IGSF6 gene and lack of association with inflammatory bowel disease. Eur J Immunogenet 2003; 30: 187-190.
29. Fisher SA, Moody A, Mirza MM, Cuthbert AP, Hampe J, MacPherson A et al. Genetic variation at the chromosome 16 chemokine gene cluster: development of a strategy for association studies in complex disease. Ann Hum Genet 2003; 67: 377-390.
30. Cuthbert AP, Fisher SA, Sanderson J, Forbes A, Lewis CM, Mathew CG. Genetic association between EPHX1 and Crohn's disease: Population stratification, genotyping error or random chance? Gut 2004; 53: 1386.
31. Mirza MM, Fisher SA, Lewis CM, Mathew CG. Failure to replicate the association of a functional NFκB1 promoter polymorphism with ulcerative colitis in a British case control cohort. Gut 2005; 54: 1206.
32. Lewontin R. The Interaction of Selection and Linkage. II. Optimum models. Genetics 1964; 50: 757-782.
33. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995; 29: 311-322.
34. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
35. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003; 25: 115-121.
36. Zhao JH, Curtis D, Sham PC. Model-free analysis and permutation tests for allelic associations. Hum Hered 2000; 50: 133-139.